Ascites Market Size is Projected to Reach USD 2240.12 Million by 2030 at 3.80% CAGR | MRFR

Market Overview

The Global Ascites Market is expected to reach USD 2240.12 million at CAGR of 3.80% between 2022 and 2030, according to a report by Market Research Future (MRFR). Ascites are a medical term for the accumulation of fluids and other substances in the abdominal cavity, which can often cause swelling in the abdomen & discomfort. It is mainly caused by cirrhosis, heart failure, and cancer, and is most commonly treated with diuretics, dietary changes, and surgical interventions. Ascites have also been linked to metabolic diseases and certain cancers, particularly pancreatic and ovarian cancer.

Market Dynamics

Some of the most prominent factors driving demand in the Ascites Market include the rising prevalence of chronic liver disorders, increasing patient population, increasing alcohol use, sedentary lifestyles, and increasing geriatric population. Market expansion is being fueled by a number of reasons, including rising consumer knowledge of treatment alternatives and technological advancements. Key market drivers include rising consumer awareness of treatment alternatives and the introduction of innovative new treatments. Market expansion is anticipated to be hampered, however, by the presence of unwanted effects from prescribed medications and a general lack of knowledge about potential treatments.

Market Segmentation

The ascites market is broken down into submarkets that focus on specific types of treatment, specific end-users, and specific geographical locations.

By treatment type, the global ascites market includes diuretics, removing ascites surgically, and others. Diuretics are expected to hold the largest share of the market in 2018, as they are the first line of treatment for ascites.

The healthcare sector, the research and development sector, and others make up the end-user segments of the market. For the duration of the study period, the market is anticipated to be led by the healthcare institution sector, specifically hospitals and clinics. Market expansion is anticipated on the back of rising technological availability and rising patient choice for hospitals and clinics.

Explore In-depth Details: Ascites Market research report

Regional Analysis

The global ascites market is segmented into North America, Europe, Asia Pacific Region (APAC), and the Rest of the World (RoW).

One of the greatest contributors to the worldwide ascites industry is anticipated to come from North America. This is because of the developed healthcare infrastructure and the strong healthcare policies already in place. It is anticipated that the availability of reimbursement policies for the treatment of ascites, as well as the increasing elderly population, will fuel market expansion. The markets in the United States and Canada, however, are expanding due to the availability of an established healthcare infrastructure and attractive reimbursement rules.

Competitive Landscape

Some of the most important companies in the ascites market are AbbVie Inc., Shionogi & Co., Ltd., AstraZeneca Plc., Merck & Co., Inc., Novartis AG, Boehringer Ingelheim GmbH, Eli Lilly and Company, Johnson & Johnson, Pfizer Inc., and Dr. Reddy's Laboratories Ltd.

Zepzelca (Lurbinectedin), a new drug developed by Merck & Co. Inc., was released in October 2018 to treat small cell lung cancer that has spread throughout the body (mSCLC).

Industry Outlook

Ascites is a common complication of cirrhosis and heart failure, and is often treated with diuretics. The global ascites market is predicted to develop due to the rising incidence of liver illnesses and the increasing availability of information about available treatments. The growth in the number of hospitals, combined with the technological advancements in treatments and increasing geriatric population, is expected to drive the growth of the market, worldwide.

Growth in the market is also anticipated to be bolstered by rising consumer knowledge of treatment options and rising per capita income. However, the side effects of treated drugs and lack of awareness about available treatments are expected to impede growth.

Companies Profiled

AbbVie Inc., Shionogi & Co., Ltd., AstraZeneca Plc., Merck & Co Inc., Novartis AG, Boehringer Ingelheim GmbH, Eli Lilly and Company, Johnson & Johnson, Pfizer Inc., and Dr. Reddy's Laboratories Ltd. are among the top companies in the Ascendis Pharma Market.

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028